As of 2025-07-01, the EV/EBITDA ratio of Twist Bioscience Corp (TWST) is -15.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Twist's latest enterprise value is 1,994.02 mil USD. Twist's TTM EBITDA according to its financial statements is -131.24 mil USD. Dividing these 2 quantities gives us the above Twist EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.6x | 12.8x |
| Forward P/E multiples | 12.3x - 16.7x | 14.0x |
| Fair Price | (23.47) - (26.19) | (25.95) |
| Upside | -163.8% - -171.2% | -170.5% |
| Date | EV/EBITDA |
| 2025-06-30 | -15.09 |
| 2025-06-27 | -14.80 |
| 2025-06-26 | -15.26 |
| 2025-06-25 | -15.29 |
| 2025-06-24 | -14.76 |
| 2025-06-23 | -14.53 |
| 2025-06-20 | -14.21 |
| 2025-06-18 | -14.78 |
| 2025-06-17 | -13.88 |
| 2025-06-16 | -14.39 |
| 2025-06-13 | -13.70 |
| 2025-06-12 | -13.75 |
| 2025-06-11 | -14.45 |
| 2025-06-10 | -14.13 |
| 2025-06-09 | -13.63 |
| 2025-06-06 | -12.81 |
| 2025-06-05 | -12.24 |
| 2025-06-04 | -12.29 |
| 2025-06-03 | -12.50 |
| 2025-06-02 | -12.58 |
| 2025-05-30 | -11.77 |
| 2025-05-29 | -11.59 |
| 2025-05-28 | -11.33 |
| 2025-05-27 | -11.82 |
| 2025-05-23 | -11.30 |
| 2025-05-22 | -11.25 |
| 2025-05-21 | -11.40 |
| 2025-05-20 | -12.51 |
| 2025-05-19 | -12.27 |
| 2025-05-16 | -12.52 |
| 2025-05-15 | -12.14 |
| 2025-05-14 | -11.87 |
| 2025-05-13 | -13.14 |
| 2025-05-12 | -13.44 |
| 2025-05-09 | -12.47 |
| 2025-05-08 | -13.29 |
| 2025-05-07 | -13.36 |
| 2025-05-06 | -13.35 |
| 2025-05-05 | -14.80 |
| 2025-05-02 | -16.31 |
| 2025-05-01 | -15.61 |
| 2025-04-30 | -15.89 |
| 2025-04-29 | -16.51 |
| 2025-04-28 | -16.61 |
| 2025-04-25 | -16.71 |
| 2025-04-24 | -16.74 |
| 2025-04-23 | -15.57 |
| 2025-04-22 | -15.26 |
| 2025-04-21 | -14.18 |
| 2025-04-17 | -15.20 |